Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Clinical trial NCT03657420 · WITHDRAWN
Trial details
- NCT number
- NCT03657420
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2021-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.